Getting Recovery Right After Neck Dissection (GRRAND-F): Mixed-methods feasibility study to design a pragmatic randomised controlled trial

Smith, Toby O. ORCID: https://orcid.org/0000-0003-1673-2954, Garrett, Angela, Liu, Tianshu, Morris, Alana, Gallyer, Victoria, Fordham, Bethany A., Dutton, Susan J., Chester-Jones, Mae, Lamb, Sarah E. and Winter, Stuart Charles (2023) Getting Recovery Right After Neck Dissection (GRRAND-F): Mixed-methods feasibility study to design a pragmatic randomised controlled trial. Frontiers in Oncology, 13. ISSN 2234-943X

[thumbnail of 1110500_Manuscript_submitted_revisions_V1.0_06Feb2023_accepted]
Preview
PDF (1110500_Manuscript_submitted_revisions_V1.0_06Feb2023_accepted) - Accepted Version
Available under License Creative Commons Attribution.

Download (696kB) | Preview

Abstract

Objective: To determine the feasibility of a randomised controlled trial to estimate the effectiveness and cost-effectiveness of a rehabilitation intervention following neck dissection (ND) after head and neck cancer (HNC). Design: Two-arm, open, pragmatic, parallel, multicentre, randomised controlled feasibility trial. Setting: Two UK NHS hospitals. Participants: People who had HNC in whom a ND was part of their care. We excluded those with a life expectancy of six months or less, pre-existing, long-term neurological disease affecting the shoulder and cognitive impairment. Intervention: Usual care (standard care supplemented with a booklet on postoperative self-management) was received by all participants. The GRRAND intervention programme consisted of usual care plus up to six individual physiotherapy sessions including neck and shoulder range of motion and progressive resistance exercises, advice and education. Between sessions, participants were advised to complete a home exercise programme. Randomisation: 1:1 randomisation. Allocation was based on minimisation, stratified by hospital site and spinal accessory nerve sacrifice. It was not possible to mask treatment received. Main outcome measures: Primary: Participant recruitment, retention and fidelity to the study protocol and interventions from study participants and staff at six months post-randomisation (and 12 months for those reaching that time-point). Secondary: clinical measures of pain, function, physical performance, health-related quality of life, health utilisation and adverse events. Results: 36 participants were recruited and enrolled. The study achieved five of its six feasibility targets. These included consent - 70% of eligible participants were consented; intervention fidelity - 78% participants discharged completed the intervention sessions; contamination - none - no participants in the control arm received the GRRAND-F intervention and retention - 8% of participants were lost to follow-up. The only feasibility target that was not achieved was the recruitment target where only 36 of the planned 60 participants were recruited over 18 months. This was principally due to the COVID-19 pandemic which caused all research activity to be paused or reduced, with a subsequent reduction in. Conclusions: Based on the findings a full-trial can now be designed to better understand whether this proposed intervention is effective. Clinical Trial Registration: https://www.isrctn.com/ISRCTN1197999, identifier ISRCTN11979997.

Item Type: Article
Additional Information: Funding: This study was funded by the National Institute for Health Research (NIHR) Research for Patient Benefit grant (PB-PG-1217- 20031). The study was supported by the Oxford Clinical Trials Research Unit, University of Oxford and the National Institute for Health and Care Research Oxford Biomedical Research Centre. SEL was supported by the National Institute for Health and Care Research Exeter Biomedical Research Centre. GRRAND-F Collaborators: Miss Harriet Finze (Oxford University Hospital NHS Foundation Trust), Mr Ray Derkacz (Patient and Public Member), Sites: Principal Investigators: Mr Richard Sisson, Norfolk and Norwich University Hospitals NHS Foundation Trust; Mr Stuart Winter, Oxford University Hospital NHS Foundation Trust; Ms Emma King, Poole Hospital NHS Foundation Trust; Professor Hisham Mehanna, University Hospitals Birmingham NHS Foundation Trust. Trial Steering Committee: Professor Matthew Maddocks (Kings College London), Professor Vinidh Paleri (The Royal Marsden Hospital NHS Foundation Trust, London).
Uncontrolled Keywords: rehabilitation,physiotherapy,neck dissection,head neck cancer,feasibility,rehabilitation,head and neck,cancer,shoulder,surgery,oncology,cancer research,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2730
Faculty \ School: Faculty of Medicine and Health Sciences > School of Health Sciences
UEA Research Groups: Faculty of Science > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Groups > Health Promotion
Faculty of Medicine and Health Sciences > Research Centres > Population Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 27 Feb 2023 10:32
Last Modified: 19 Oct 2023 03:33
URI: https://ueaeprints.uea.ac.uk/id/eprint/91277
DOI: 10.3389/fonc.2023.1110500

Actions (login required)

View Item View Item